![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TCEA1 |
Gene summary for TCEA1 |
![]() |
Gene information | Species | Human | Gene symbol | TCEA1 | Gene ID | 6917 |
Gene name | transcription elongation factor A1 | |
Gene Alias | GTF2S | |
Cytomap | 8q11.23 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | P23193 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6917 | TCEA1 | GSM4909281 | Human | Breast | IDC | 1.16e-03 | 2.79e-01 | 0.21 |
6917 | TCEA1 | GSM4909288 | Human | Breast | IDC | 2.43e-06 | 5.99e-03 | 0.0988 |
6917 | TCEA1 | GSM4909293 | Human | Breast | IDC | 1.24e-07 | 3.10e-01 | 0.1581 |
6917 | TCEA1 | GSM4909294 | Human | Breast | IDC | 1.38e-07 | 2.45e-01 | 0.2022 |
6917 | TCEA1 | GSM4909296 | Human | Breast | IDC | 7.51e-10 | -1.86e-01 | 0.1524 |
6917 | TCEA1 | GSM4909297 | Human | Breast | IDC | 3.24e-15 | -4.75e-02 | 0.1517 |
6917 | TCEA1 | GSM4909309 | Human | Breast | IDC | 1.14e-04 | -1.02e-01 | 0.0483 |
6917 | TCEA1 | GSM4909311 | Human | Breast | IDC | 9.77e-32 | -5.86e-02 | 0.1534 |
6917 | TCEA1 | GSM4909312 | Human | Breast | IDC | 1.10e-25 | 4.55e-01 | 0.1552 |
6917 | TCEA1 | GSM4909313 | Human | Breast | IDC | 4.69e-05 | 6.05e-02 | 0.0391 |
6917 | TCEA1 | GSM4909317 | Human | Breast | IDC | 1.87e-57 | 1.01e+00 | 0.1355 |
6917 | TCEA1 | GSM4909318 | Human | Breast | IDC | 6.73e-50 | 1.33e+00 | 0.2031 |
6917 | TCEA1 | GSM4909319 | Human | Breast | IDC | 5.76e-43 | -6.62e-02 | 0.1563 |
6917 | TCEA1 | GSM4909320 | Human | Breast | IDC | 1.66e-06 | -1.55e-01 | 0.1575 |
6917 | TCEA1 | GSM4909321 | Human | Breast | IDC | 8.06e-15 | -2.12e-01 | 0.1559 |
6917 | TCEA1 | M2 | Human | Breast | IDC | 9.09e-05 | 1.88e-01 | 0.21 |
6917 | TCEA1 | M5 | Human | Breast | IDC | 2.81e-03 | 5.54e-01 | 0.1598 |
6917 | TCEA1 | NCCBC14 | Human | Breast | DCIS | 5.83e-14 | 2.61e-02 | 0.2021 |
6917 | TCEA1 | NCCBC2 | Human | Breast | DCIS | 2.18e-10 | 8.27e-02 | 0.1554 |
6917 | TCEA1 | NCCBC5 | Human | Breast | DCIS | 2.52e-15 | -7.16e-02 | 0.2046 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003206912 | Breast | IDC | regulation of nuclease activity | 8/1434 | 22/18723 | 1.40e-04 | 2.49e-03 | 8 |
GO:003206922 | Breast | DCIS | regulation of nuclease activity | 8/1390 | 22/18723 | 1.13e-04 | 2.00e-03 | 8 |
GO:00320698 | Esophagus | ESCC | regulation of nuclease activity | 19/8552 | 22/18723 | 9.52e-05 | 6.78e-04 | 19 |
GO:00320695 | Liver | Cirrhotic | regulation of nuclease activity | 11/4634 | 22/18723 | 9.18e-03 | 4.21e-02 | 11 |
GO:003206911 | Liver | HCC | regulation of nuclease activity | 18/7958 | 22/18723 | 1.91e-04 | 1.49e-03 | 18 |
GO:00320697 | Oral cavity | OSCC | regulation of nuclease activity | 20/7305 | 22/18723 | 6.02e-07 | 8.64e-06 | 20 |
GO:003206913 | Oral cavity | LP | regulation of nuclease activity | 14/4623 | 22/18723 | 1.23e-04 | 1.44e-03 | 14 |
GO:00320699 | Skin | cSCC | regulation of nuclease activity | 14/4864 | 22/18723 | 2.22e-04 | 1.83e-03 | 14 |
GO:003206914 | Thyroid | PTC | regulation of nuclease activity | 15/5968 | 22/18723 | 5.11e-04 | 3.32e-03 | 15 |
GO:003206923 | Thyroid | ATC | regulation of nuclease activity | 17/6293 | 22/18723 | 3.47e-05 | 2.84e-04 | 17 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TCEA1 | SNV | Missense_Mutation | c.434N>T | p.Arg145Met | p.R145M | P23193 | protein_coding | tolerated(0.08) | possibly_damaging(0.898) | TCGA-A8-A08R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TCEA1 | SNV | Missense_Mutation | c.316N>C | p.Glu106Gln | p.E106Q | P23193 | protein_coding | tolerated(0.24) | benign(0.1) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
TCEA1 | SNV | Missense_Mutation | c.569N>C | p.Arg190Thr | p.R190T | P23193 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-BH-A0HP-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | doxorubicin | SD | |
TCEA1 | insertion | Frame_Shift_Ins | novel | c.376_377insGG | p.Tyr126TrpfsTer18 | p.Y126Wfs*18 | P23193 | protein_coding | TCGA-AR-A0TY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | PD | ||
TCEA1 | SNV | Missense_Mutation | novel | c.287C>T | p.Thr96Ile | p.T96I | P23193 | protein_coding | deleterious(0.04) | benign(0.017) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
TCEA1 | SNV | Missense_Mutation | c.338N>A | p.Val113Glu | p.V113E | P23193 | protein_coding | tolerated(1) | benign(0.01) | TCGA-VS-A9UR-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
TCEA1 | SNV | Missense_Mutation | c.841G>A | p.Ala281Thr | p.A281T | P23193 | protein_coding | deleterious(0) | possibly_damaging(0.901) | TCGA-A6-2686-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TCEA1 | SNV | Missense_Mutation | rs762271675 | c.742N>T | p.His248Tyr | p.H248Y | P23193 | protein_coding | deleterious(0.02) | possibly_damaging(0.808) | TCGA-AA-3949-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
TCEA1 | SNV | Missense_Mutation | novel | c.709N>T | p.Arg237Trp | p.R237W | P23193 | protein_coding | deleterious(0) | possibly_damaging(0.72) | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TCEA1 | SNV | Missense_Mutation | rs199869556 | c.394N>T | p.Arg132Trp | p.R132W | P23193 | protein_coding | deleterious(0.03) | possibly_damaging(0.586) | TCGA-AA-3982-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |